Lv5
920 积分 2023-03-30 加入
Effects of the Dual Endothelin Antagonist Aprocitentan on Ambulatory Blood Pressure Indices in Patients With Resistant Hypertension— Results From the Precision Study
6小时前
待确认
On the dual of 𝐵𝑉
6小时前
待确认
On the dual of 𝐵𝑉
7小时前
已关闭
A Game Changer for Resistant Hypertension: The Rise of Aprocitentan
1天前
求助中
After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension
1天前
求助中
Population pharmacokinetics of the dual endothelin receptor antagonist aprocitentan in subjects with or without essential or resistant hypertension
1天前
待确认
The Dual Endothelin-1 Antagonist Aprocitentan Alleviates Mitochondrial Oxidative Stress in Human Cardiac Fibroblasts
1天前
求助中
Aprocitentan for Blood Pressure Reduction in Black Patients
1天前
已完结
Efficacy and Safety of Aprocitentan in the Treatment of Hypertension: A Meta-Analysis of Evidence from Randomized Controlled Trials
1天前
已完结
皖公网安备34019202002308
